Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Automation Opportunities in Pharmacovigilance: An Industry Survey
47
Zitationen
6
Autoren
2020
Jahr
Abstract
Our results highlight the areas of greatest opportunity for intelligent automation based on the potential benefits of applying intelligent automation and the perceived risks associated with each ICSR process step. Responding TransCelerate member companies already automate many steps to varying degrees. However, a significant opportunity remains for automation to penetrate further. Additionally, the pharmacovigilance industry culture needs to change in order to reduce the perceived risk of automation and to encourage a more progressive approach to intelligent automation. Increased automation is crucial to empower agile and efficient pharmacovigilance.
Ähnliche Arbeiten
A method for estimating the probability of adverse drug reactions
1981 · 11.446 Zit.
Incidence of Adverse Drug Reactions in Hospitalized Patients
1998 · 4.798 Zit.
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
2004 · 3.193 Zit.
Adverse drug reactions: definitions, diagnosis, and management
2000 · 2.924 Zit.
Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group
1995 · 2.509 Zit.